Please join us at 12:00 PM GMT +01:00 on Feburary 26th, 2026 in welcoming Catherine Seet-Lee, Elisa Esposito, and Erica Schleicher for their talks (details provided below)

• Catherine Seet-Lee, PhD Candidate, Faculty of Medicine and Health, University of Sydney, NSW, Australia. The effect of intra-infusion exercise on chemotherapy side effects: the EX-FUSION study
• Elisa Esposito, PhD candidate in Sport and Exercise Sciences, South East Technological University, Ireland. Digital Health Resources promoting Physical Activity among People Living with and beyond Cancer: An Environmental Scan.
• Erica Schleicher, Postdoctoral Scholar – University of Pittsburgh, Pittsburgh, US. Evaluating Re-Triage Patterns in an Exercise Oncology Triage and Referral System.

Registration link: https://ubc.ca1.qualtrics.com/jfe/form/SV_a8FO9sxiJVRLqWa

Please join us at 12:00 PM EST on March 19th, 2026 in welcoming Dr. Kerri Winters-Stone for her talk on Reducing falls and frailty in cancer survivors: Trials and tribulations of clinical exercise trials with non-continuous outcomes.

This talk will present the design, conduct, analytic and interpretation of two clinical exercise oncology trials designed to reduce falls and frailty in cancer survivors: GET FIT and GET FIT Prostate. There are unique challenges with clinical trials with primary outcomes that are event rates or categorical data that impact the design, analysis and interpretation of study success or failure. In addition to presenting study outcomes, these challenges will be discussed along with where to go in this field in the future.

Registration link will be available Feburary 27th, 2026.

Please join us at 9:00 AM CEST on April 23rd, 2026 in welcoming Dr. David Barlett for his talk on Utilising cancer mechanisms to optimise exercise training – a lesson learned from chronic lymphocytic leukaemia (CLL).

Chronic cancers like CLL are typically either low-grade and do not require immediate treatment (i.e., active monitoring or watch-and-wait) or a higher grade requiring long-term therapies designed to put the disease into remission. Life expectancy is high, but in both cases, patients have increased risks of severe infections leading to hospitalisation, poor quality of life and death. Their cancer drives immunosuppression, premature frailty and life-altering chronic fatigue. In this presentation, Dr Bartlett will discuss the underlying mechanisms that likely drive their poor quality of life and how these mechanisms can be utilised to design optimal exercise approaches that improve their outcomes.

Registration link will be available April 2nd, 2026.